BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 4, 2012
View Archived Issues
Ammonia scavenger assessed in healthy volunteers and patients with cirrhosis
Read More
Results disclosed from ENABLE trials
Read More
Genentech ADC shows potential in prostate cancer models
Read More
Novel NCK1/TCR interaction inhibitors designed in Spain
Read More
New biologicals with anticancer potential discovered in Belgium
Read More
Merck Sharp & Dohme patents novel HER3-specific antibodies
Read More
Theravance presents in vivo results on its new SSRI candidate
Read More
Novel potential therapies for obesity discovered at Bristol-Myers Squibb
Read More
Caisson Biotech forms licensing agreement with Novo Nordisk
Read More
FDA approves Levaquin for new indication
Read More
Novavax launches phase I trial of A/H5N1 flu vaccine candidate
Read More
GenVec obtains NIH grant for respiratory syncytial virus vaccine program
Read More
D-Pharm receives first payment from DP-VPA agreement
Read More
Transbuccal insulin film produces encouraging first-in-human results
Read More
Novel Shp2 inhibitors developed in Germany
Read More
NRC discloses new single-domain monoclonal antibodies
Read More
Additional patients achieve independence from parenteral support in STEPS 2 study
Read More
St. Jude Children's Research Hospital presents new Mdm2/Mdm4 antagonists
Read More
Idera Pharmaceuticals reports topline phase II IMO-2055 data
Read More
Lead Sunesis product receives European orphan drug status
Read More
Omeros unlocks additional class A orphan GPCRs
Read More
FDA identifies deficiencies in Adasuve NDA
Read More
CSL Behring kicks off study of volume-reduced C1-INH in HAE
Read More
FDA extends priority review of crofelemer NDA
Read More
Lexicon Pharmaceuticals receives funds to support phase II testing in type 1 diabetes
Read More
